Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Glaukos Corp. (NYSE: GKOS).

Full DD Report for GKOS

You must become a subscriber to view this report.


Recent News from (NYSE: GKOS)

Glaukos' iStent shows long-term benefit in glaucom study
Glaukos (NYSE: GKOS ) announces positive results from a multiyear single-site study evaluating the iStent inject Trabecular Micro-Bypass System, combined with cataract surgery, in glaucoma patients. The data were just published in the journal Ophthalmology and Therapy . More news on: Gl...
Source: SeekingAlpha
Date: December, 11 2018 16:48
Glaukos iStent inject® Implantation with Concomitant Cataract Surgery Provides Sustained Reduction in IOP and Medication Burden, According to New Study
Three-Year Outcomes Reveal 37% Mean IOP Decline to 14.3 mmHg, 68% Decline in Mean Number of Topical Ocular Hypotensive Medications and Favorable Safety Profile Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and ...
Source: Business Wire
Date: December, 11 2018 16:15
Consolidated Research: 2018 Summary Expectations for The Hackett Group, Green Plains, Malibu Boats, Hawaiian Electric Industries, Iridium Communications, and Glaukos - Fundamental Analysis, Key Performance Indications
NEW YORK, Nov. 27, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The Hackett Group, Inc. (NASDAQ:HCKT), Green Plains, Inc. (NASDAQ:GPRE), ...
Source: GlobeNewswire
Date: November, 27 2018 07:45
Glaukos misses by $0.05, beats on revenue
Glaukos (NYSE: GKOS ): Q3 GAAP EPS of -$0.19 misses by $0.05 . More news on: Glaukos, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: November, 07 2018 16:31
Glaukos Corporation Announces Third Quarter 2018 Financial Results
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, today announced financial results f...
Source: Business Wire
Date: November, 07 2018 16:10
Notable earnings after Wednesday's close
AAOI , ADT , ALB , ALRM , AMBC , ANGI , ANSS , ARNA , ATO , AVID , AVLR , AYX , BREW , CABO , CARG , CASA , CISN , CSGS , CSOD , CTRP , CVNA , CYBR , DVA , ECPG , EDIT , ENS , ENV , ET , EVC , EVRG , FARM , FG , FLO , FLS , FOSL , GDOT , GKOS , HK , HO...
Source: SeekingAlpha
Date: November, 06 2018 17:35
A Migrating Biotech Bear
Biotech Pulse Biotechnology is in a Bear Market. At least the midcap and smallcap segment of it. The S&P Biotechnology Select Index ( XBI ), which is weighted towards the midcap and smallcap companies, has dropped 24% from its high recorded on August 30 to its lowest point past Monda...
Source: SeekingAlpha
Date: November, 06 2018 08:39
This Stock Reset Requires Patience
Halloween is here, but the goblins seem to have lost their way into the stock market. And they're creating havoc! The relentless volatility and a drip of near-daily 1-2% decline are darkening investor confidence and making it a month of terror. What started as a question of whether the Feder...
Source: SeekingAlpha
Date: October, 29 2018 15:53
Today's Research Reports on Trending Tickers: Inogen and Glaukos
NEW YORK, NY / ACCESSWIRE / October 23, 2018 / Major U.S. equities finished lower Monday on a combination of rising interest rates and global growth concerns. Investors await a flood of corporate earnings this week as over 150 companies are scheduled to release earnings. The Dow Jones Indust...
Source: ACCESSWIRE IA
Date: October, 23 2018 08:00
Glaukos Corporation to Release Third Quarter 2018 Financial Results after Market Close on November 7
Conference Call and Webcast Scheduled for 1:30 p.m. PST Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transf...
Source: Business Wire
Date: October, 17 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1463.5062.7766.078661.3527702,478
2017-11-2725.2825.7925.8224.881,109,323
2017-11-2424.6425.2925.4224.27478,580
2017-11-2225.4524.5025.4523.441,916,199
2017-11-2128.1525.3528.1525.201,355,803

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-185,70711,71048.7361Short
2018-12-176,03321,74927.7392Cover
2018-12-142,9787,08642.0265Short
2018-12-134,09914,66127.9585Cover
2018-12-1248,74364,71175.3241Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on GKOS.


About Glaukos Corp. (NYSE: GKOS)

Logo for Glaukos Corp. (NYSE: GKOS)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $1,208,446,447 - 05/18/2018
  • Issue and Outstanding: 34,906,021 - 05/07/2018

 


Recent Filings from (NYSE: GKOS)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 05 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 05 2018
Specialized Disclosure Report
Filing Type: SDFiling Source: edgar
Filing Date: May, 31 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 09 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 18 2018

 

 


Daily Technical Chart for (NYSE: GKOS)

Daily Technical Chart for (NYSE: GKOS)


Stay tuned for daily updates and more on (NYSE: GKOS)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: GKOS)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in GKOS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of GKOS and does not buy, sell, or trade any shares of GKOS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/